Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen Hawthorne

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioanalysis|October 17, 2019
Overcoming analytical challenges to generate data critical to understanding lipid nanoparticle-delivered modified mRNA biodistributionGlen Hawthorne, Neil Henderson, Mikko Hölttä, et al.
Bioanalysis|July 14, 2015
Validation of an ultrasensitive LC-MS/MS method for PTH 1-34 in porcine plasma to support a solid dose PK studyRichard G Kay, Jonathan T Hands, Glen Hawthorne, et al.
Bioanalysis|April 12, 2019
Feedback from the European Bioanalysis Forum liquid microsampling consortium: capillary liquid microsampling and assessment of homogeneity of the resultant samplesZoe Cobb, Morten Rohde, Iain Love, et al.
Translational Oncology|September 23, 2025
Camizestrant causes reversible pharmacological effects on retinal responses in ratsGregory Hamm, Gareth Maglennon, Stuart Purbrick, et al.
Bioanalysis|April 12, 2019
Feedback from the European Bioanalysis Forum liquid microsampling consortium: microsampling: assessing accuracy and precision of handheld pipettes and capillariesGlen Hawthorne, Lieve Dillen, Matthew Barfield, et al.
Toxicology and Applied Pharmacology|March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanismAndrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.
Bioanalysis|February 4, 2021
The effectiveness of quality control samples in pharmaceutical bioanalysisStephen Keller, Jorge Quiroz, Dave Christopher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2021
Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogsV Sashi Gopaul, Elsbet J Pieterman, Hans M G Princen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and TrapperGiuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1Anna D Staniszewska, Domenic Pilger, Sonja J Gill, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioanalysis|October 17, 2019
Overcoming analytical challenges to generate data critical to understanding lipid nanoparticle-delivered modified mRNA biodistributionGlen Hawthorne, Neil Henderson, Mikko Hölttä, et al.
Bioanalysis|July 14, 2015
Validation of an ultrasensitive LC-MS/MS method for PTH 1-34 in porcine plasma to support a solid dose PK studyRichard G Kay, Jonathan T Hands, Glen Hawthorne, et al.
Bioanalysis|April 12, 2019
Feedback from the European Bioanalysis Forum liquid microsampling consortium: capillary liquid microsampling and assessment of homogeneity of the resultant samplesZoe Cobb, Morten Rohde, Iain Love, et al.
Translational Oncology|September 23, 2025
Camizestrant causes reversible pharmacological effects on retinal responses in ratsGregory Hamm, Gareth Maglennon, Stuart Purbrick, et al.
Bioanalysis|April 12, 2019
Feedback from the European Bioanalysis Forum liquid microsampling consortium: microsampling: assessing accuracy and precision of handheld pipettes and capillariesGlen Hawthorne, Lieve Dillen, Matthew Barfield, et al.
Toxicology and Applied Pharmacology|March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanismAndrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.
Bioanalysis|February 4, 2021
The effectiveness of quality control samples in pharmaceutical bioanalysisStephen Keller, Jorge Quiroz, Dave Christopher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2021
Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogsV Sashi Gopaul, Elsbet J Pieterman, Hans M G Princen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and TrapperGiuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1Anna D Staniszewska, Domenic Pilger, Sonja J Gill, et al.
Pageof 1